Pharmacologic Cardiac Stress Test Agent Drug Class List
✉ Email this page to a colleague
Drugs in Drug Class: Pharmacologic Cardiac Stress Test Agent
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | REGADENOSON | regadenoson | SOLUTION;INTRAVENOUS | 215827-001 | Feb 2, 2023 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Mylan | REGADENOSON | regadenoson | SOLUTION;INTRAVENOUS | 213856-001 | Apr 4, 2023 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Accord Hlthcare | REGADENOSON | regadenoson | SOLUTION;INTRAVENOUS | 213236-001 | Apr 11, 2022 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Gland Pharma Ltd | REGADENOSON | regadenoson | SOLUTION;INTRAVENOUS | 207320-001 | Jul 12, 2022 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Baxter Hlthcare Corp | REGADENOSON | regadenoson | SOLUTION;INTRAVENOUS | 217455-001 | May 23, 2023 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Meitheal | REGADENOSON | regadenoson | SOLUTION;INTRAVENOUS | 212806-001 | Apr 11, 2022 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
